Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema
Authors
Keywords
-
Journal
Immunotherapy
Volume 6, Issue 5, Pages 533-551
Publisher
Future Medicine Ltd
Online
2014-03-17
DOI
10.2217/imt.14.33
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: A systematic literature review
- (2013) Konrad Bork et al. ALLERGY AND ASTHMA PROCEEDINGS
- Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks
- (2013) Timothy J. Craig et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Hereditary Angioedema with Normal C1 Inhibitor
- (2013) Konrad Bork IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema
- (2013) T. Caballero et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema
- (2013) Daniel Sexton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Berinert® (C1-Esterase Inhibitor Concentrate) Treatment Is Not Related to Prothrombotic Risk Based On Preclinical Efficacy and Safety Investigations
- (2013) Eva Herzog et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks
- (2012) Timothy J. Craig et al. ALLERGY AND ASTHMA PROCEEDINGS
- International consensus on hereditary and acquired angioedema
- (2012) David M. Lang et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Current Management Options for Hereditary Angioedema
- (2012) Konrad Bork CURRENT ALLERGY AND ASTHMA REPORTS
- Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies
- (2012) V. Wahn et al. EUROPEAN JOURNAL OF PEDIATRICS
- Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate
- (2012) K. Bork et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency
- (2012) Konrad Bork et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients
- (2012) Henriette Farkas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database
- (2012) Pranav K. Gandhi et al. PHARMACOTHERAPY
- Pathogen safety of human C1 esterase inhibitor concentrate
- (2012) Albrecht Gröner et al. TRANSFUSION
- WAO Guideline for the Management of Hereditary Angioedema
- (2012) Timothy Craig et al. World Allergy Organization Journal
- Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
- (2011) M. Cicardi et al. ALLERGY
- C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study
- (2011) T. J. Craig et al. ALLERGY
- Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial
- (2011) William R. Lumry et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
- (2011) J.J. Hofstra et al. CLINICAL IMMUNOLOGY
- International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency
- (2011) Teresa Caballero et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study
- (2011) Konrad Bork et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
- Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema
- (2011) Wolfhart Kreuz et al. TRANSFUSION
- The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression
- (2010) William R. Lumry et al. ALLERGY AND ASTHMA PROCEEDINGS
- Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate
- (2010) Inmaculada Martinez-Saguer et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema
- (2010) Alvin E. Davis ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema
- (2010) Tom Bowen et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients
- (2010) Konrad Bork et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis
- (2010) Kusumam Joseph et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Economic costs associated with acute attacks and long-term management of hereditary angioedema
- (2010) David A. Wilson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks
- (2010) Jonathan A. Bernstein et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey
- (2010) Ibolya Czaller et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week
- (2010) Konrad Bork et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Short-term Prophylaxis With C1-inhibitor Concentrate In Patients With Hereditary Angioedema Prior To Surgical Procedures
- (2010) E. Rusicke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
- (2010) Bruce Zuraw et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema
- (2010) Marco Cicardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
- (2010) Bruce L. Zuraw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
- (2010) Marco Cicardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks
- (2009) Timothy J. Craig et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study
- (2009) Inmaculada Martinez-Saguer et al. TRANSFUSION
- Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema
- (2008) K. Bork et al. ALLERGY
- Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
- (2008) Andreas Lehmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Therapeutic potential of icatibant (HOE-140, JE-049)
- (2008) Nicholas LM Cruden et al. EXPERT OPINION ON PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started